Debt to Equity
since 2005
Calculation
Abiomed Inc., debt to equity, long-term trends, calculation
| Debt to equity | = | Capital lease obligation1 | ÷ | Stockholders’ equity1 | |
|---|---|---|---|---|---|
| Mar 31, 2022 | 0.00 | = | —) | ÷ | 1,503,326) |
| Mar 31, 2021 | 0.00 | = | —) | ÷ | 1,329,675) |
| Mar 31, 2020 | 0.00 | = | —) | ÷ | 1,065,466) |
| Mar 31, 2019 | 0.00 | = | —) | ÷ | 936,890) |
| Mar 31, 2018 | 0.00 | = | —) | ÷ | 689,524) |
| Mar 31, 2017 | 0.04 | = | 16,338) | ÷ | 452,071) |
| Mar 31, 2016 | 0.00 | = | —) | ÷ | 368,775) |
| Mar 31, 2015 | 0.00 | = | —) | ÷ | 291,560) |
| Mar 31, 2014 | 0.00 | = | —) | ÷ | 168,353) |
| Mar 31, 2013 | 0.00 | = | —) | ÷ | 137,080) |
| Mar 31, 2012 | 0.00 | = | —) | ÷ | 126,297) |
| Mar 31, 2011 | 0.00 | = | —) | ÷ | 104,743) |
| Mar 31, 2010 | 0.00 | = | —) | ÷ | 107,956) |
| Mar 31, 2009 | 0.00 | = | —) | ÷ | 115,983) |
| Mar 31, 2008 | 0.00 | = | —) | ÷ | 93,594) |
| Mar 31, 2007 | 0.00 | = | —) | ÷ | 122,095) |
| Mar 31, 2006 | 0.00 | = | —) | ÷ | 69,488) |
| Mar 31, 2005 | 0.00 | = | —) | ÷ | 56,179) |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
1 US$ in thousands
Stockholders' equity demonstrates a sustained and significant long-term growth trend from 2005 through 2022. The equity base expanded from 56.18 million US dollars in 2005 to 1.50 billion US dollars by March 31, 2022.
- Equity Growth Patterns
- Initial growth was characterized by moderate fluctuations between 2005 and 2011, with equity peaking at 122.10 million US dollars in 2007 before experiencing minor contractions in 2008 and 2010. Starting in 2012, a period of accelerated expansion began, with equity increasing from 126.30 million US dollars to 1.50 billion US dollars over the following decade. The most rapid accumulation of equity occurred between 2017 and 2022, during which the value more than tripled.
- Debt and Leverage Analysis
- The organization maintains a highly conservative capital structure with minimal reliance on external borrowing. For the vast majority of the observed period, debt levels were not reported, suggesting an absence of significant long-term liabilities. In 2017, the reporting of a capital lease obligation of 16.34 million US dollars resulted in a debt-to-equity ratio of 0.04. This extremely low ratio indicates that equity financing heavily outweighs debt obligations, reflecting a low-risk leverage profile and strong internal solvency.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Comparison to Competitors
Abiomed Inc., debt to equity, long-term trends, comparison to competitors
| Abiomed Inc. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Mar 31, 2022 | 0.00 | 0.46 | 0.66 | 0.00 | 0.46 | 0.74 |
| Mar 31, 2021 | 0.00 | 0.50 | 0.64 | 0.00 | 0.51 | 0.64 |
| Mar 31, 2020 | 0.00 | 0.57 | 0.60 | 0.00 | 0.49 | 0.66 |
| Mar 31, 2019 | 0.00 | 0.58 | 0.63 | 0.00 | 0.51 | 0.71 |
| Mar 31, 2018 | 0.00 | 0.64 | 0.67 | 0.00 | 0.51 | 0.71 |
| Mar 31, 2017 | 0.04 | 0.90 | 0.75 | 0.00 | 0.66 | 0.66 |
| Mar 31, 2016 | 0.00 | 1.07 | 0.63 | 0.00 | 0.60 | 0.86 |
| Mar 31, 2015 | 0.00 | 0.42 | 0.69 | 0.00 | 0.68 | 0.95 |
| Mar 31, 2014 | 0.00 | 0.36 | 0.62 | 0.00 | 0.61 | 0.54 |
| Mar 31, 2013 | 0.00 | 0.26 | 0.59 | 0.00 | 0.57 | 0.52 |
| Mar 31, 2012 | 0.00 | 0.77 | 0.63 | 0.00 | 0.62 | 0.54 |
| Mar 31, 2011 | 0.00 | 0.63 | 0.42 | 0.00 | 0.62 | 0.41 |
| Mar 31, 2010 | 0.00 | 0.85 | 0.38 | 0.00 | 0.65 | 0.43 |
| Mar 31, 2009 | 0.00 | 0.72 | 0.34 | 0.00 | 0.57 | 0.47 |
| Mar 31, 2008 | 0.00 | 0.65 | 0.41 | 0.00 | 0.60 | 0.62 |
| Mar 31, 2007 | 0.00 | 0.69 | 0.39 | 0.00 | 0.55 | 0.55 |
| Mar 31, 2006 | 0.00 | 0.88 | 0.29 | 0.00 | 0.84 | 0.36 |
| Mar 31, 2005 | 0.00 | 0.46 | 0.27 | 0.00 | 0.23 | 0.40 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Sector (Health Care Equipment & Services)
Abiomed Inc., debt to equity, long-term trends, comparison to sector (health care equipment & services)
| Abiomed Inc. | Health Care Equipment & Services | |
|---|---|---|
| Mar 31, 2022 | 0.00 | 0.57 |
| Mar 31, 2021 | 0.00 | 0.55 |
| Mar 31, 2020 | 0.00 | 0.56 |
| Mar 31, 2019 | 0.00 | 0.58 |
| Mar 31, 2018 | 0.00 | 0.60 |
| Mar 31, 2017 | 0.04 | 0.71 |
| Mar 31, 2016 | 0.00 | 0.72 |
| Mar 31, 2015 | 0.00 | 0.69 |
| Mar 31, 2014 | 0.00 | 0.52 |
| Mar 31, 2013 | 0.00 | 0.47 |
| Mar 31, 2012 | 0.00 | 0.61 |
| Mar 31, 2011 | 0.00 | 0.49 |
| Mar 31, 2010 | 0.00 | 0.55 |
| Mar 31, 2009 | 0.00 | 0.51 |
| Mar 31, 2008 | 0.00 | 0.55 |
| Mar 31, 2007 | 0.00 | 0.53 |
| Mar 31, 2006 | 0.00 | 0.50 |
| Mar 31, 2005 | 0.00 | 0.34 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).
Comparison to Industry (Health Care)
Abiomed Inc., debt to equity, long-term trends, comparison to industry (health care)
| Abiomed Inc. | Health Care | |
|---|---|---|
| Mar 31, 2022 | 0.00 | 0.72 |
| Mar 31, 2021 | 0.00 | 0.80 |
| Mar 31, 2020 | 0.00 | 0.92 |
| Mar 31, 2019 | 0.00 | 0.90 |
| Mar 31, 2018 | 0.00 | 0.80 |
| Mar 31, 2017 | 0.04 | 0.82 |
| Mar 31, 2016 | 0.00 | 0.77 |
| Mar 31, 2015 | 0.00 | 0.69 |
| Mar 31, 2014 | 0.00 | 0.54 |
| Mar 31, 2013 | 0.00 | 0.50 |
| Mar 31, 2012 | 0.00 | 0.54 |
| Mar 31, 2011 | 0.00 | 0.47 |
| Mar 31, 2010 | 0.00 | 0.43 |
| Mar 31, 2009 | 0.00 | 0.42 |
| Mar 31, 2008 | 0.00 | 0.42 |
| Mar 31, 2007 | 0.00 | 0.36 |
| Mar 31, 2006 | 0.00 | 0.32 |
| Mar 31, 2005 | 0.00 | 0.30 |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).